Replies to post #247702 on Biotech Values

[DewDiligence]

Astonishingly, FGEN’s 83% selloff_today_was_outdone_by AVTX, down 89% on phase-2 failure in asthma:

https://finance.yahoo.com/news/avalo-announces-topline-data-phase-110000563.html

[DewDiligence]

FGEN reduces workforce 32%—(104 employees):

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000921299/000095017023033458/fgen-20230714.htm

The surprising thing is that after the layoff FGEN will still have about 220 employees. What will they all be doing?

No press release.